{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&_metadata=all&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&_page=0&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "items" : [{"_about" : "http://data.parliament.uk/resources/1605953", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1605953/answer", "answerText" : {"_value" : "<p>The Home Office Drug and Firearms Licensing Unit (DFLU) considers applications for premises and company specific controlled drug licences.<\/p><p>All applications are considered individually and on their merits, after undertaking a physical site visit- if one is needed- and reviewing the evidence submitted to support an application. A prospective licensee may need to demonstrate that product(s) meet the criteria to be considered medicines, and that there is an evidenced need for them. DFLU cannot comment on individual licence applications that may have been made to it.<\/p><p>The General Pharmaceutical Council (GPhC) is the independent regulator for pharmacists, pharmacy technicians and pharmacy premises in Great Britain.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2023-03-27", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-03-27T16:28:25.583Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2023-03-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, whether her Department plans to extend Target Pharmacy's licence for Bedrocan products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "170649"}
    , {"_about" : "http://data.parliament.uk/resources/1538289", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1538289/answer", "answerText" : {"_value" : "<p>The information requested is not held centrally.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
        }
        , "answeringMemberConstituency" : {"_value" : "Colchester"}
        , "answeringMemberPrinted" : {"_value" : "Will Quince"}
        , "dateOfAnswer" : {"_value" : "2022-11-08", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-11-08T17:16:44.407Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-11-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people are prescribed cannabis-based medicines via private healthcare services in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "76000"}
    , {"_about" : "http://data.parliament.uk/resources/1247151", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247151/answer", "answerText" : {"_value" : "<p>Two prescription medicines - Sativex \u2013 for the treatment of spasticity in Multiple Sclerosis patients, and Epidyolex \u2013 for the treatment of seizures associated with two rare forms of epilepsy, have been made available for prescribing on the National Health Service, where clinically appropriate. This follows clear demonstrated evidence of their safety, and clinical and cost effectiveness.<\/p><p>We continue to work hard with the health system, industry and researchers to improve the evidence base for other cannabis-based medicines, and to implement the recommendations of NHS England and NHS Improvement\u2019s review on barriers to accessing unlicensed cannabis based medicinal products. This includes the design of clinical trials and the establishment of a national patient registry.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-11-17", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-11-17T13:43:29.213Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department (a) is taking to improve access to medicinal cannabis for people living with multiple sclerosis and (b) if he will publish a Government strategy for improving access to medicinal cannabis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "109474"}
    , {"_about" : "http://data.parliament.uk/resources/1247153", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247153/answer", "answerText" : {"_value" : "<p>There have been 1,700 items for Sativex prescribed on an NHS prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement for the period November 2019 to August 2020, the latest data available. The following table shows the number of items by month.<\/p><table><tbody><tr><td><p>Month<\/p><\/td><td><p>Items<\/p><\/td><\/tr><tr><td><p>November 2019<\/p><\/td><td><p>172<\/p><\/td><\/tr><tr><td><p>December 2019<\/p><\/td><td><p>177<\/p><\/td><\/tr><tr><td><p>January 2020<\/p><\/td><td><p>175<\/p><\/td><\/tr><tr><td><p>February 2020<\/p><\/td><td><p>160<\/p><\/td><\/tr><tr><td><p>March 2020<\/p><\/td><td><p>177<\/p><\/td><\/tr><tr><td><p>April 2020<\/p><\/td><td><p>187<\/p><\/td><\/tr><tr><td><p>May 2020<\/p><\/td><td><p>154<\/p><\/td><\/tr><tr><td><p>June 2020<\/p><\/td><td><p>167<\/p><\/td><\/tr><tr><td><p>July 2020<\/p><\/td><td><p>178<\/p><\/td><\/tr><tr><td><p>August 2020<\/p><\/td><td><p>153<\/p><\/td><\/tr><\/tbody><\/table><p><br>The NHS Business Service Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-based products dispensed in the community in England. This information is being withheld in accordance with the General Data Protection Regulation, due to the number of items attributed to less than five patients and potential for patient identifiable information to be published.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-11-17", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "109475"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-11-17T14:04:54.27Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-10-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many prescriptions for unlicensed cannabis-based medicines the NHS issued in 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "109476"}
    , {"_about" : "http://data.parliament.uk/resources/1229118", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1229118/answer", "answerText" : {"_value" : "<p>The patient registry for cannabis-based products for medicinal use is currently being developed by NHS England and NHS Improvement with input from specialist clinicians and other advisory bodies. The purpose of this registry is to collect a uniform data set for patients prescribed these products, including patient outcomes. NHS England and NHS Improvement intends to pilot the registry this autumn, to enable operational use as soon as practicable.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-09-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-09-14T18:28:31.767Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-08-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 June 2020 to Question 57346 on Cannabis: Medical Treatments, what progress the Government has made on implementing a patient registry to monitor outcomes among medical cannabis patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "82094"}
    , {"_about" : "http://data.parliament.uk/resources/1229119", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1229119/answer", "answerText" : {"_value" : "<p>The NHS Business Services Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-based products dispensed in community pharmacy in England. This information is being withheld in accordance with the General Data Protection Regulation, due to the number of items attributed to less than five patients and potential for patient identifiable information to be published.<\/p><p>313 private prescription items for unlicensed cannabis-based products were prescribed and dispensed in community pharmacy in England (November 2018 \u2013 February 2020). During the COVID-19 outbreak, the NHS Business Services Authority temporarily suspended the processing of private prescriptions of this nature, so data between March 2020 and August 2020 is currently unavailable.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-09-14", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "82096"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-09-14T19:12:55.627Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-08-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many unlicensed cannabis-based products have been prescribed on an NHS prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement in each month from November 2018 to August 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "82095"}
    , {"_about" : "http://data.parliament.uk/resources/1229120", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1229120/answer", "answerText" : {"_value" : "<p>The NHS Business Services Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-based products dispensed in community pharmacy in England. This information is being withheld in accordance with the General Data Protection Regulation, due to the number of items attributed to less than five patients and potential for patient identifiable information to be published.<\/p><p>313 private prescription items for unlicensed cannabis-based products were prescribed and dispensed in community pharmacy in England (November 2018 \u2013 February 2020). During the COVID-19 outbreak, the NHS Business Services Authority temporarily suspended the processing of private prescriptions of this nature, so data between March 2020 and August 2020 is currently unavailable.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-09-14", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "82095"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-09-14T19:12:55.677Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-08-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many private prescription items for unlicensed cannabis-based medicines have been prescribed and submitted to the NHS Business Services Authority in each month from November 2018 to August 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "82096"}
    , {"_about" : "http://data.parliament.uk/resources/1189310", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1189310/answer", "answerText" : {"_value" : "<p>There have been 3,546 items for licensed and unlicensed cannabis-based medicines prescribed on a National Health Service prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement for the period November 2018 to February 2020 (latest data available).<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-05-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-05-04T13:01:12.42Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-04-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many prescriptions for cannabis-based products for medicinal use have been issued on the NHS since the rescheduling of those products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "39000"}
    , {"_about" : "http://data.parliament.uk/resources/1189313", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1189313/answer", "answerText" : {"_value" : "<p>The Department continues to work closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) to maintain the supply of unlicensed cannabis-based products for medicinal use (CBPMs) to ensure that patients with prescriptions from specialist doctors can access their medicine. The Home Office and the MHRA treat all import requests for CBPMs as emergency supplies, and on receipt of the correct documentation, applicants receive decisions within a few working days.<\/p><p>The Government made changes to import policy in March 2020 to enable pharmaceutical wholesalers to apply to import CBPMs in anticipation of prescriptions, instead of only applying to import the quantity specified on a prescription. We are continuing to work with industry to ensure supply remains uninterrupted during the COVID-19 outbreak.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-05-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-05-04T13:04:04.123Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-04-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the guidance entitled, The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use in humans specials, published by the Medicines and Healthcare Products Regulatory Agency in March 2020, what discussions officials in his Department have had with officials in the Home Office on ensuring that import licences for cannabis-based products for medicinal use are granted without delay; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "39003"}
    , {"_about" : "http://data.parliament.uk/resources/1173615", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1173615/answer", "answerText" : {"_value" : "<p>We are aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed cannabis-based products for medicinal use. It is clear that for some products, long lead times and delays in receiving export licences from the authorities in the country of manufacture, have led to delays in the supply against prescriptions and pose a potential risk to patients receiving their medicines on time.<\/p><p>The Department, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement are in the process of agreeing what action can be taken to help alleviate these delays, including exploring mechanisms to allow licensed wholesalers to hold a small reserve stock linked to an evidenced demand by specialist prescribers; and ensuring that the United Kingdom meets its obligations under the Single Convention on Narcotic Drugs. Any changes will be reflected in the guidance published by the MHRA.<\/p><p>In the meantime, the Home Office and the MHRA are treating all import requests for cannabis-based products for medicinal use as emergency supplies and on receipt of the correct documentation, applicants can expect a decision within a few working days.<\/p><p>No meetings have taken place with representatives of patient groups concerning the reported delays to imports of cannabis-base products for medicinal use. Officials did meet with patient groups in the development of this policy when the previous Government rescheduled cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001.<\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2020-02-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "8360"}
        , {"_value" : "8361"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-02-04T17:26:56.3Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2020-01-27", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions officials of his Department has had with officials of the Home Office to ensure there are no undue delays in granting import licences for cannabis-based products for medicinal use; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "8359"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Ronnie+Cowan&_page=1&min-ddpModified.=2020-02-04T16%3A26%3A04.347Z&hansardHeading=Cannabis%3A+Medical+Treatments", "page" : 0, "startIndex" : 1, "totalResults" : 14, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}